Follow The Filings

IVZ Invesco

Invesco earnings company data as of 11:59 AM ET 10/23

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 27 Oct EPS 0.75 — —
Rev — — —

Insider trades

Open-market buys and sales by IVZ's executives, directors and 10% owners in the last 12 months, from their Form 4s

All IVZ insider trades
  • None no insider bought on the open market
  • $11M sold by 5 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Phoebe A Wood Director
    Sale
    $97K 3,000 shares at $32.44 2.7% of stake
    Traded Sep 11 Filed Sep 14
  2. Stephanie Butcher Senior Managing Director
    Sale
    $1.5M 45,095 shares at $32.28 82% of stake
    Traded Sep 9 Filed Sep 10
  3. Andrew Tak Shing Lo Senior Managing Director
    Sale
    $4.6M 143,370 shares at $32.39 15% of stake
    Traded Sep 8–9 Filed Sep 10
  4. Laura Allison Dukes CFO
    Sale
    $1M 31,075 shares at $33.16 11% of stake
    Traded Sep 4 Filed Sep 9
  5. Douglas J Sharp Senior Managing Director
    Sale
    $3.8M 160,000 shares at $23.56 100% of stake
    Traded Oct 31, 2025 Filed Nov 3, 2025

Also filed in the last 12 months, not counted as buying or selling: 40 stock grants, 22 share withholdings for taxes, 2 gifts, and 1 option exercise.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
8-K/A 7.01,9.01
8-K 7.01,9.01
8-K 7.01,9.01
8-K 5.02,7.01,9.01
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13G —
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13G —
SCHEDULE 13G —
SCHEDULE 13G —
SCHEDULE 13G —
SCHEDULE 13G —
SCHEDULE 13G —
SCHEDULE 13G —
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13G —
SCHEDULE 13G/A —

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.